Explorer les evidences

1,37 adjusted_odds_ratioHigher parity was independently associated with HBV infection in pregnancy, with an adjusted odds ratio of 1.37.

Nigeriahépatite Bobservé November 1, 2017 to April 30, 2018publié 2020Annals of African medicinePubMeddocument de 5 observations

3,3 %The prevalence of hepatitis B surface antigen (HBsAg) in the study population was 3.3%.

Nigeriahépatite Bpublié 2025American journal of clinical pathologyPubMeddocument de 5 observations

5,3 %The prevalence of HBV infection using HBsAg was 5.3% among HIV-infected children in Lagos.

Nigeriahépatite B · VIH/sidapublié 2020PloS onePubMeddocument de 4 observations

23,3 %The prevalence of hepatitis B surface antigen (HBsAg) among patients attending public hospitals in Lagos, Nigeria was 23.3%.

Nigeriahépatite Bpublié 2025The Nigerian postgraduate medical journalPubMeddocument de 7 observations

9,3 %Drug-resistant associated HBV variants were detected in 9.3% of cases.

Nigeriahépatite Bobservé 2018publié 2025Pathogens (Basel, Switzerland)PubMeddocument de 8 observations

0 %The mother-to-child transmission (MTCT) rate for HIV, HBV, and HCV among pregnant women in Nigeria was 0% at 6-week post-delivery.

Nigeriahépatite B · hépatite C · VIH/sidaobservé 6-week post-deliverypublié 2025Antiviral therapyPubMeddocument de 7 observations

8 %Among all donors tested for transfusion transmissible infections, 761 (8.0%) tested positive for Hepatitis B.

Nigeriahépatite Bobservé 2020-2022publié 2025BMC infectious diseasesPubMeddocument de 17 observations

1,6 %HBV genotype A was found in 1.6% of cases in Nigeria.

Nigeriahépatite Bobservé 2018publié 2025Pathogens (Basel, Switzerland)PubMeddocument de 8 observations

9,93 fLMean platelet volume (MPV) of 9.93 ± 1.1 fL in SCD individuals with HBV was significantly higher than 8.30 ± 0.95 fL in SCD individuals without HBV.

Nigeriahépatite Bpublié 2021West African journal of medicineeurope_pmcdocument de 4 observations

20 casesAmong 250 patients with HIV/AIDS screened for HBV, 20 (8%) were identified as HBV-infected.

Nigeriahépatite B · VIH/sidapublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 11 observations

7,63 %The overall hepatitis B positivity rate in Nigeria was 7.63%.

Nigeriahépatite Bobservé 2018publié 2021Annals of global healthPubMeddocument de 12 observations

1,92 adjusted_odds_ratioAge was significantly associated with HBV vaccination completion, with an adjusted odds ratio of 1.92 (95% CI: 1.23, 3.03) in Lagos state, Nigeria.

Nigeriahépatite Bobservé June 2021 to June 2024publié 2026PloS onePubMeddocument de 12 observations

10 %The prevalence of anti-HBs among 150 PLHIV in the study was 10%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

17,7 %Among PLHIV aged 51–60 years, the prevalence of HBsAg was 17.7%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

58,4 %The HBV vaccination completion rate was 58.4% among participants aged 30–34 years in Lagos state, Nigeria.

Nigeriahépatite Bobservé June 2021 to June 2024publié 2026PloS onePubMeddocument de 12 observations

10,9 %HBV prevalence among study participants was 10.9%.

Nigeriahépatite Bobservé 2009-12publié 2016PloS onePubMeddocument de 14 observations

81,3 %One hundred and twenty-two (81.3%) of 150 PLHIV tested negative to all hepatitis B virus markers.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

6 %The prevalence of Hepatitis B co-infection among people living with HIV/AIDS in a rural Northern Nigerian community was 6.0%.

Nigeriahépatite B · VIH/sidapublié 2020The Pan African medical journalPubMeddocument de 4 observations

45,4 %The overall HBV vaccination completion rate was 45.4% among 641 study participants in Lagos state, Nigeria.

Nigeriahépatite Bobservé June 2021 to June 2024publié 2026PloS onePubMeddocument de 12 observations

1,3 %In 2019, the hepatitis B virus (HBV) positivity rate among screened pregnant women in the South East zone of Nigeria was 1.3%.

Nigeriahépatite Bobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 10 observations

2,5 %In 2019, the hepatitis B virus (HBV) screening rate among pregnant women in the North East zone of Nigeria was 2.5%.

Nigeriahépatite Bobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 10 observations

22,2 %A high prevalence of 22.2% (6 out of 27) of HBV resistance mutations was detected among ART-experienced HBV-HIV-coinfected patients in southwestern Nigeria.

Nigeriahépatite B · VIH/sidapublié 2019Antiviral therapyPubMeddocument de 4 observations

57,4 %57.4% of subjects were infected with chronic HBV (HBsAg+).

Nigeriacarcinome hépatocellulaire · hépatite Bpublié 2021Tropical medicine & international health : TM & IHPubMeddocument de 15 observations

2 700 000 peopleGlobally, approximately 2.7 million people living with HIV are co-infected with hepatitis B virus.

Nigeriahépatite B · VIH/sidapublié 2024Journal of infection in developing countriesPubMeddocument de 5 observations

1,8 %Among female PLHIV participants, the prevalence of anti-HBs was 1.8%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations